OmniStar Financial Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,966
Closed -$689K 118
2025
Q4
$689K Buy
1,966
+378
+24% +$128K 0.4% 66
2025
Q3
$513K Buy
+1,588
New +$494K 0.31% 80
2024
Q4
Sell
-1,744
Closed -$912K 123
2024
Q3
$912K Buy
1,744
+133
+8% +$71.1K 0.68% 39
2024
Q2
$873K Buy
1,611
+13
+0.8% +$6.87K 0.79% 36
2024
Q1
$829K Buy
+1,598
New +$795K 0.76% 35
2020
Q2
Sell
-220
Closed -$50K 176
2020
Q1
$50K Buy
+220
New +$60K 0.05% 133

Other funds holding ELV

OmniStar Financial Group's ELV Position: Q1 2026 in Review

OmniStar Financial Group sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 1,966 shares — an estimated $689K sold.

OmniStar Financial Group first reported a position in ELV in Q1 2020 and held it in 6 quarters. The position peaked at $912K in Q3 2024. 1,469 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • OmniStar Financial Group reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
  • OmniStar Financial Group sold 1,966 Elevance Health shares in Q1 2026, an estimated $689K.
  • OmniStar Financial Group first reported a position in Elevance Health in Q1 2020 and held it in 6 quarters.
  • OmniStar Financial Group's Elevance Health position peaked at $912K in Q3 2024.
  • 1,469 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on OmniStar Financial Group's 13F filing for Q1 2026, filed 15 May 2026.